Monash IVF Group Ltd (AU:MVF)
ASX:MVF
Want to see AU:MVF full AI Analyst Report?
MVF Stock Chart & Stats
AU$0.76
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.76
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.54 - AU$0.90
Previous CloseN/A
Volume300.99K
Average Volume (3M)2.18M
Market Cap
AU$278.59M
Enterprise ValueAU$562.35M
Total Cash (Recent Filing)AU$8.14M
Total Debt (Recent Filing)AU$281.81M
Price to Earnings (P/E)10.0
Beta1.20
Next Earnings
Aug 24, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend Yield6.22%
Share Statistics
EPS (TTM)0.04
Shares Outstanding389,634,830
10 Day Avg. Volume1,374,502
30 Day Avg. Volume2,181,726
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.84Price Target Upside9.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$267.01M
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Profit GrowthA large reported revenue increase supports a durable expansion in patient volumes or service mix, underpinning scalable revenue streams. Sustained top-line growth enables reinvestment in clinics, hiring of specialists and longer-term market share gains in assisted reproductive services.
Solid MarginsRelatively strong gross and net margins indicate structural profitability from clinical and laboratory services, giving room to absorb cost inflation and invest in service quality. Combined with ROE (~10.2%), margins support sustainable earnings generation and capital returns over time.
Specialised Clinic Network And Recurring ModelA clinic/lab network and specialist staff create high structural barriers and recurring revenue from treatment cycles and follow-ups. This business model produces predictable demand from patient cohorts and referrals, supporting durable cash flows and competitive positioning in fertility services.
Bears Say
Severe Free Cash Flow DeclineA near-total collapse in free cash flow materially weakens the company's ability to self-fund capex, pay dividends or absorb shocks. Over the medium term this can force external financing, constrain strategic investments and reduce flexibility in an industry requiring ongoing lab and equipment spend.
Weak Cash ConversionLow cash conversion signals earnings quality and working capital strain: reported profits are not translating into cash. Persistently weak conversion increases reliance on financing, raises vulnerability to payment timing swings, and undermines sustainable funding for growth initiatives.
Rising Debt LevelsHigher leverage tightens financial flexibility and raises fixed interest obligations. In a sector with capex and staffing intensity, elevated debt increases refinancing and interest-rate risk, limiting capacity for acquisitions or new clinic openings and amplifying downside in earnings stress scenarios.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.54 and its highest was AU$0.90 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$278.59M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 24, 2026 which is in 95 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Feb 25, 2026. The company reported AU$0.018 earnings per share for the quarter, missing the consensus estimate of AU$0.025 by -AU$0.007.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Semiannually dividend of AU$0.026 which represents an annual dividend yield of 6.22%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.02.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of AU$0.018 in its last earnings report, missing expectations of AU$0.025. Following the earnings report the stock price went up 2.954%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.84 (9.87% Upside)
AU$0.84 (9.87% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 94%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
6.06%
Trailing 12-Months
Asset Growth
0.49%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.84
▲(9.87% Upside)
Technical Analysis
Healius Limited
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---